Human lithostathine S2-5: A relevant inhibitor of pancreatic stone formation?

被引：5

作者：

Bimmler, D ^{[1
]}

Graf, R ^{[1
]}

Frick, T ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Surg, Pancreatitis Res Lab, CH-8091 Zurich, Switzerland

来源：

PANCREAS | 1999年 / 18卷 / 04期

关键词：

D O I：

10.1097/00006676-199905000-00015

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：417 / 418

页数：2

共 6 条

[1] Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor? [J].

Bimmler, D ;

Graf, R ;

Scheele, GA ;

Frick, TW .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :3073-3082

[2] Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals [J].

De Reggi, M ;

Gharib, B ;

Patard, L ;

Stoven, V .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4967-4971

[3] PURIFICATION AND ASSAY OF SECRETORY LITHOSTATHINE IN HUMAN PANCREATIC-JUICE BY FAST PROTEIN LIQUID-CHROMATOGRAPHY [J].

MARIANI, A ;

MEZZI, G ;

MALESCI, A .

GUT, 1995, 36 (04) :622-629

[4] PANCREATIC STONE PROTEIN - QUANTIFICATION IN PANCREATIC-JUICE BY ENZYME-LINKED IMMUNOSORBENT-ASSAY AND COMPARISON WITH OTHER METHODS [J].

PROVANSALCHEYLAN, M ;

MARIANI, A ;

BERNARD, JP ;

SARLES, H ;

DUPUY, P .

PANCREAS, 1989, 4 (06) :680-689

[5] IMMUNOCHEMICAL CHARACTERIZATION AND QUANTITATIVE DISTRIBUTION OF PANCREATIC STONE PROTEIN IN SERA AND PANCREATIC SECRETIONS IN PANCREATIC DISORDERS [J].

SCHMIEGEL, W ;

BURCHERT, M ;

KALTHOFF, H ;

ROEDER, C ;

BUTZOW, G ;

GRIMM, H ;

KREMER, B ;

SOEHENDRA, N ;

SCHREIBER, HW ;

THIELE, HG ;

GRETEN, H .

GASTROENTEROLOGY, 1990, 99 (05) :1421-1430

[6] Quantification of human lithostathine S2-5 forms using the antibody to the N-terminal peptide region [J].

Yamadera, K ;

Wada, K ;

Goto, M ;

Yokoyama, K ;

Morita, Y ;

Kitano, Y ;

Makino, I .

PANCREAS, 1998, 16 (04) :475-480

← 1 →